OTC Monograph Reform May Have To Launch Without User Fees, Senate Sponsor Says

 
• By Malcolm Spicer

"We believe that we're going to get this done," but "it's possible that ... language authorizing the collection of user fees is not included in this year's appropriation legislation," says Sen. Bob Casey during HELP Committee's confirmation hearing for FDA commissioner nominee Stephen Hahn.

Hand holds the magnifying glass in front of an open notebook. Among the many icons, attention is focused on the money icon. Financial operations, banking, lending, etc.

A US Senate sponsor of an OTC drug monograph reform bill expects the legislation to pass this year but also sees a chance that the corresponding user fee program wouldn't be part of the Food and Drug Administration's next appropriation.

"We believe that we're going to get this done and get this passed. It will be up to the FDA to swiftly implement the legislation," said Sen

More from Legislation

More from Policy & Regulation